Assembly Biosciences, Inc. ASMB
21.29 USD +0.17 (+0.80%)
Regular-session close
21.29 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
21.00 Day range 21.81
19.20 52-week range 39.71
- YTD
- -37.40%
- 1 year
- -42.00%
News
zacks.com Assembly Biosciences (ASMB) Reports Q3 Loss, Lags Revenue Estimates Assembly Biosciences (ASMB) came out with a quarterly loss of $0.93 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to a loss of $0.72 per share a year ago.
globenewswire.com Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates – Initiated Phase 2 clinical study of ABI-6250 in patients with chronic hepatitis delta virus infection –benzinga.com UBS Maintains Buy on Assembly Biosciences, Lowers Price Target to $48 UBS analyst Ashwani Verma maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and lowers the price target from $52 to $48.
globenewswire.com Assembly Biosciences to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver…benzinga.com Assembly Biosciences Doses First Two Patients In Its Phase 2 Clinical Trial Of ABI-6250 To Treat Chronic Hepatitis Delta Virus Infection Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced dosing of the first two participants…
globenewswire.com Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus – Phase 2 study will evaluate the safety, pharmacokinetics and antiviral activity of ABI-6250 in participants with chronic HDV infection – – Initial data from the Phase 2 study is expected in the…
defenseworld.net Analyzing RYTHM (NASDAQ:RYM) and Assembly Biosciences (NASDAQ:ASMB) Assembly Biosciences (NASDAQ: ASMB - Get Free Report) and RYTHM (NASDAQ: RYM - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two…
globenewswire.com Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026 ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction
zacks.com Best Momentum Stocks to Buy for September 17th MSGM, ASMB and MTG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 17th, 2026.
zacks.com New Strong Buy Stocks for September 17th MOV, MAX, MTG, ASMB and MSGM have been added to the Zacks Rank #1 (Strong Buy) List on September 17th, 2026.
globenewswire.com Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver…
zacks.com Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks COCO, CHEF, ASMB and CDNA stand out as four defensive picks amid volatility induced by rising oil prices and Middle East tensions.
globenewswire.com Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program – Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes –
zacks.com Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High? The average of price targets set by Wall Street analysts indicates a potential upside of 35.7% in Assembly Biosciences (ASMB). While the effectiveness of this highly sought-after metric is…
zacks.com Should You Buy Assembly Biosciences (ASMB) After Golden Cross? Assembly Biosciences, Inc. (ASMB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ASMB's 50-day simple moving average broke out…
zacks.com 5 Stocks With Recent Price Strength Buoyed by a Strong August EDRY, RCMT, ASMB, DCTH and NESR show strong recent price momentum after a strong August, backed by improving earnings expectations.
zacks.com Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going Assembly Biosciences (ASMB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
zacks.com Best Momentum Stocks to Buy for August 25th LQDT, IA and ASMB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 25th, 2026.
zacks.com New Strong Buy Stocks for August 25th IA, ASMB, LQDT, OFG and TGT have been added to the Zacks Rank #1 (Strong Buy) List on August 25th, 2026.
zacks.com Best Momentum Stocks to Buy for August 21st LITE, ONTO and ASMB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 21st, 2026.
zacks.com New Strong Buy Stocks for August 21st MCY, ASMB, ONTO, BSET and UNH have been added to the Zacks Rank #1 (Strong Buy) List on August 21st, 2026.
zacks.com Are You Looking for a Top Momentum Pick? Why Assembly Biosciences (ASMB) is a Great Choice Does Assembly Biosciences (ASMB) have what it takes to be a top stock pick for momentum investors? Let's find out.
